PS152 Ivabradine in Patients With Non-ST Elevation Acute Coronary Syndrome and Primary Percutaneous Intervention. Valeria: A Pilot Study

Non-ST elevation acute coronary syndrome (NSTE-ACS) is the commonest acute presentation of coronary artery disease. Despite an increase in the rate of primary percutaneous coronary intervention (PCI), medical therapy continues to retain a central rol in the treatment of these frail patients and heart rate (HR) at discharge correlates with mortality. Ivabradine is a pure HR reducing agent that has no effect on blood pressure and increases coronary flow reserve, being a new option that could improve the prognosis of this population.
Source: CVD Prevention and Control - Category: Global & Universal Authors: Tags: Poster Abstract Source Type: research